Interpace Diagnostics Group Inc. buy melinda
Start price
29.06.17
/
50%
€8.03
Target price
24.08.17
€15.33
Performance (%)
40.45%
End price
24.08.17
€11.28
Summary
This prediction ended on 24.08.17 with a price of €11.28. With a performance of 40.45% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Interpace Diagnostics Group Inc. | - | - | - | - |
| iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
| iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
| iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
| iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
Comments by melinda for this prediction
In the thread Interpace Diagnostics Group Inc. diskutieren
Interpace
Interpace Diagnostics kündigte einen nationalen Vertrag mit Aetna
28. Juni (Reuters) - Interpace Diagnostics Group Inc: Interpace Diagnostics kündigte einen nationalen Vertrag mit Aetna.Interpace Diagnostics Group - Einem neuen nationalen Vertrag mit Aetna für seine molekularen Tests und THYGENX Thyramir für unbestimmten Schilddrüsenknoten.
Stopped prediction by melinda for Interpace Diagnostics Group Inc.
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€12.27
23.10.17
23.10.17
€15.33
26.12.17
26.12.17
-30.88%
26.12.17
26.12.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€13.60
23.10.17
23.10.17
€17.00
26.12.17
26.12.17
-30.88%
26.12.17
26.12.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€20.32
07.04.17
07.04.17
€30.67
18.04.17
18.04.17
68.51%
18.04.17
18.04.17